Average Pharmaceutical Email Benchmarks
The pharmaceutical industry operates under some of the most stringent regulatory frameworks in email marketing. Marketers must navigate HIPAA privacy requirements in the United States, the FDA regulations governing promotional communications, and similar bodies such as the MHRA in the UK and EMA in Europe. These constraints shape every aspect of campaign design, from audience segmentation to content approval workflows. Despite these challenges, pharmaceutical email marketing consistently achieves strong engagement metrics due to the high relevance of the content for recipients.
Industry-wide data indicates that pharmaceutical email campaigns achieve average open rates between 22% and 30%, significantly outperforming the cross-industry average of approximately 21%. Click-through rates typically fall between 2.5% and 5%, while conversion rates vary widely depending on whether the goal is patient education, clinical trial recruitment, or product awareness. Bounce rates tend to remain low at 1% to 3% because pharmaceutical mailing lists are typically well-maintained and permission-based. Spam complaint rates are among the lowest across all industries, frequently below 0.01%, owing to the highly anticipated nature of communications from healthcare providers and pharmaceutical companies.
Key Findings
- Pharmaceutical email campaigns achieve open rates 5 to 10 percentage points above the all-industry average, driven by high recipient trust and medical relevance.
- Spam complaint rates are exceptionally low, often below 0.01%, due to strong permission practices and highly relevant content.
- Click-to-open rates (CTOR) range from 10% to 18%, reflecting the educational nature of most pharmaceutical email content.
- Healthcare professional (HCP) campaigns consistently outperform direct-to-consumer (DTC) campaigns by 3 to 5 percentage points in open rates.
- Regulatory review cycles add 2 to 10 business days to campaign lead times, significantly longer than non-regulated industries.
Open Rate Benchmarks
Pharmaceutical email open rates rank among the highest of any regulated industry. Patient education and disease awareness campaigns typically achieve open rates of 22% to 26%. Healthcare professional communications, including clinical data updates and prescribing information, see notably higher open rates of 26% to 30%. HCP campaigns benefit from a captive, professionally obligated audience that relies on email for continuing medical education and product updates. Seasonal campaigns, such as flu season vaccination reminders, can push open rates above 32%. Subject line strategies that reference specific conditions or treatment options tend to outperform broader health messaging by 4 to 7 percentage points.
Click-Through Rate Benchmarks
Click-through rates for pharmaceutical emails average between 2.5% and 5%, with significant variation by campaign type. HCP campaigns targeting doctors and pharmacists tend toward the higher end of this range, achieving CTRs of 4% to 5%, as recipients are actively seeking clinical information and dosing guidance. DTC patient education campaigns typically achieve CTRs of 2.5% to 4%. Email content that includes links to prescribing information, patient support programmes, or clinical study results sees higher engagement. Mobile optimisation is critical, with over 55% of pharmaceutical email opens now occurring on mobile devices, though desktop remains important for HCP segments who may read emails during clinical hours.
Best Practices
- Implement a robust email preference centre that allows recipients to select therapeutic area interests and communication frequency to maintain relevance and compliance.
- Use confirmed opt-in (double opt-in) for all DTC campaigns to ensure regulatory compliance and list quality, reducing spam complaint risk.
- Include mandatory privacy policy links and unsubscribe mechanisms in every email, ensuring compliance with HIPAA, GDPR, and FDA regulations.
- Segment HCP and patient audiences rigorously; never mix the two lists as the regulatory and informational needs differ substantially.
- Conduct pre-send legal and medical review with a documented approval workflow, budgeting 3 to 10 business days for each campaign cycle.
Related Benchmarks
Industry — Accounting Bookkeeping Email Marketing Benchmarks
Email marketing benchmarks for accounting, tax and bookkeeping firms covering tax season campaigns, client retention nurture and financial advisory content. Open rates 22-30%, CTR 2-5%.
Automotive & Car Dealership Email Marketing Benchmarks
Email marketing benchmarks for automotive dealerships and car retailers. Open rates 15-20%, CTR 2-4%, service reminders, sales events, new model launches, and test drive follow-up campaigns.
Aviation and Airlines — Email Marketing Benchmarks
Email marketing benchmarks for the aviation and airline industry including booking confirmations, flight updates, loyalty programmes, and destination marketing performance data.
B2B Email Marketing Benchmarks
B2B email marketing benchmarks for open rates, click-through rates, lead generation, and conversion metrics. Compare your professional services or B2B company's email performance against verified industry averages.
Beauty, Salon & Spa Industry Email Marketing Benchmarks
Email marketing benchmarks for beauty salons, hair salons, spas, and aesthetics clinics. Open rates 18-23%, CTR 2.5-5%, appointment reminders, product recommendations, and seasonal promotion data.
Cannabis and CBD — Email Marketing Benchmarks
Email marketing benchmarks for the cannabis, hemp, and CBD industry including ISP restrictions, age-gating requirements, and deliverability challenges with specific performance data.
Frequently Asked Questions
The primary challenges are HIPAA privacy requirements for patient data, FDA regulations on promotional claims and fair balance, and adverse event reporting obligations. Every campaign must include specific labelling information, and all claims must be supported by clinical evidence. Marketers must also maintain strict separation between patient and HCP communications to avoid regulatory breaches.
Pharmaceutical emails consistently outperform general healthcare email marketing by 3 to 5 percentage points. While the broader healthcare industry averages open rates around 18% to 22%, pharmaceutical campaigns achieve 22% to 30% due to the highly anticipated nature of condition-specific information and established doctor-patient relationships.
Monthly or quarterly frequency is typical for DTC patient education campaigns, while HCP communications may be sent bi-weekly during active clinical data releases or conference seasons. Over-sending risks increased unsubscribe rates and potential regulatory complaints, so most pharmaceutical marketers prioritise quality and relevance over volume.
Over 55% of pharmaceutical email opens occur on mobile devices. Campaigns that are not mobile-responsive see 20% to 30% lower click-through rates. This is particularly important for patient-facing emails, where recipients are likely reading on smartphones. HCP campaigns still see significant desktop readership, especially during clinical hours.
Subject lines that reference specific medical conditions, treatment options, or patient benefits consistently outperform generic health messaging. Personalisation using recipient name and condition area improves open rates by 3 to 5 percentage points. However, subject lines must avoid any language that could be construed as promotional without appropriate context, as this may trigger regulatory concerns.